文献速递外周动脉疾病

氨甲环酸与下肢动脉损伤血管重建后血栓形成及再手术相关

Tranexamic acid is associated with thrombosis and reoperation of vascular reconstructions for lower extremity arterial injuries.
PubMed 文献 · J Vasc Surg · 2026-06-12

基于PROOVIT注册研究232例下肢动脉损伤开放重建患者,33例(14.2%)接受氨甲环酸(TXA)。

要点

  • 下肢动脉损伤开放重建后接受TXA与早期重建失败风险约翻倍相关。
  • TXA组生理紊乱和输血需求更重,但骨折比例更低、静脉损伤相似。
  • 需进一步研究TXA现行给药方案在动脉重建患者中的风险获益。

核心结论

  • 下肢动脉损伤开放重建患者接受TXA与重建血栓或即刻再手术复合终点风险约2倍增加相关。

研究设计与样本

  • 基于PROOVIT前瞻性观察性血管损伤治疗注册研究,纳入25家美国创伤中心2012至2021年下肢动脉损伤开放重建患者232例。

主要发现

  • 232例中33例(14.2%)接受TXA,TXA组收缩压99 vs 125 mmHg、乳酸6.2 vs 4.2 mmol/L、24小时输注浓缩红细胞7.7 vs 4.2单位。
  • 自体静脉间置或旁路是最常见重建方式(66.8%),修复类型、抗凝使用和截肢两组无差异。

临床怎么用

  • 疑似血管损伤时创伤团队与血管外科团队应早期协作。
  • 对下肢动脉损伤开放重建患者需权衡TXA现行给药方案的风险获益。

局限性

  • 为前瞻性观察性注册研究,TXA组生理紊乱和输血需求更重,可能存在混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) is commonly administered to injured patients presenting with hemorrhagic shock. While TXA's inhibition of fibrinolysis has demonstrated some benefit in uncontrolled intracranial or intra-abdominal hemorrhage, the prothrombotic effect may put the patency of peripheral vascular reconstructions performed for arterial injuries at risk. Although TXA has been associated with venous thromboembolism, its impact on vascular reconstruction following arterial injury has not been elucidated. We aimed to examine the association between TXA and the outcomes of arterial reconstruction following vascular injuries to the lower extremity. METHODS: The PROspective Observational Vascular Injury Treatment registry captures in-hospital, trauma-specific outcomes related to vascular injuries across 25 US trauma centers. The registry was queried for patients with lower extremity arterial injuries who underwent open reconstruction between 2012 and 2021. Cases were categorized based on documented administration of TXA. The primary outcome measurement was a composite of reconstruction thrombosis and/or immediate reoperation. RESULTS: Among 232 lower extremity injuries that underwent reconstruction during the study period, 33 patients (14.2%) received TXA. TXA recipients demonstrated greater physiologic derangement and transfusion requirements (systolic blood pressure, 99 vs 125 mmHg; lactate, 6.2 vs 4.2 mmol/L; 7.7 vs 4.2 units packed red blood cells in 24 hours). There were fewer fractures among TXA-treated limbs compared with non-TXA-treated limbs (24.2% vs 44.2%; P = .031), but concomitant venous injury was similar (39.4% vs 36.7%; P = .765). Autologous vein interposition or bypass was the most common reconstruction (66.8%), and repair type, anticoagulation use, and limb loss did not differ between groups. TXA was associated with a 2.1-fold increase in the composite end point of arterial reconstruction thrombosis or immediate reoperation (24.2% vs 11.6%; relative risk, 2.10; 95% confidence interval, 1.00-4.40; P = .048). CONCLUSIONS: Administration of TXA in patients undergoing open lower-extremity reconstruction for arterial injuries was associated with a twofold increase in the risk of early reconstruction failure, despite a more proximal injury distribution in TXA recipients and no difference in overall complication rates. The standard bolus + 8-hour infusion protocol of TXA may extend antifibrinolytic activity into the operative period when the coagulopathy of trauma has already shifted toward a procoagulant state. Although TXA remains an important resuscitative tool, these findings support further investigation into the risk-benefit profile of current dosing protocols in patients undergoing extremity arterial reconstruction and early collaboration between trauma and vascular surgery teams when vascular injury is suspected.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cabot JH, Knowlton LM, Kauvar DS, et al. Tranexamic acid is associated with thrombosis and reoperation of vascular reconstructions for lower extremity arterial injuries. J Vasc Surg. 2026. PMID: 42285185. doi:10.1016/j.jvs.2026.05.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。